Nasdaq Could Delist Marlborough Co.

Exact Sciences Corp., a Marlborough company that develops cancer screening technology, has received a noncompliance notice from the Nasdaq Stock Market, the company announced.

The company said the notice faulted it for failing to maintain the minimum $50 million market capitalization required for continued listing. If the company does not regain compliance by maintaining the $50 million balance for at least 10 straight business days before August 11, it could be delisted.

If Exact cannot meet the requirement, it said, it may apply to transfer to the Nasdaq Capital Market. That market requires that a company maintain $2.5 million minimum stockholders' equity or $35 million minimum market capitalization. The company said it believes it meets the requirements for listing on the capital market.